Adjuvant endocrinotherapy of postmenopausal patients with breast cancer

Por V. F. Semiglazov, A. A. Malodusheva, V. G. Ivanov, P. V. Krivorotko
Publicado em 2014-09-01

Results of organ-preserving treatment of breast cancer using intraoperative radial therapy

Por I. S. Chumachenko, R. A. Murashko, A. A. Keshabyan, P. V. Krivorotko, S. N. Novikov
Publicado em 2021-10-01

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer

Por T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov
Publicado em 2014-07-01

Comparison of cosmetic results after treatment in women with breast cancer who received additional radiation to the tumor bed

Por I. A. Akulova, S. N. Novikov, A. I. Tseluyko, A. V. Chernaya, Zh. V. Bryantseva, P. V. Krivorotko, S. V. Kanaev
Publicado em 2021-01-01

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)

Por V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev
Publicado em 2015-09-01

Future prospects for breast cancer immunotherapy

Por V. F. Semiglazov, A. I. Tseluiko, R. V. Donskikh, P. V. Krivorotko, G. A. Dashyan, V. V. Semiglazov, A. V. Komyakhov
Publicado em 2018-11-01

Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemot...

Por P V Krivorotko, O N Burdaeva, M N Nechaeva, M A Frolova, M V Kopp, A A Abrosimova, R A Ivanov
Publicado em 2015-06-01

Post-neoadjuvant treatment of breast cancer

Por V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko
Publicado em 2020-07-01

Utility of dual-energy contrast-enhanced spectral mammography for the diagnosis of multicentric breast cancer

Por A. V. Chyornaya, R.  Kh. Ulyanova, P.  V. Krivorotko, A. S. Artemyeva, S. S. Bagnenko, E. K. Zhiltsova, S. N. Novikov, V. V. Danilov, P.  I. Krzhivitskiy, V. F. Semiglazov
Publicado em 2022-01-01

The role of digital mammography, scintimammography with ^99mTc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer

Por A. V. Chernaya, P. I. Krzhivitskiy, E. A. Busko, P. V. Krivorotko, A. S. Artemyeva, N. S. Popova, V. V. Danilov, V. F. Semiglazov, S. N. Novikov, S. V. Kanaev
Publicado em 2020-03-01

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe...

Por E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov
Publicado em 2017-02-01

New prospects in the use of Kadcyla® in breast cancer

Por G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, R. M. Paltuev, E. E. Topuzov, T. Yu. Semiglazova, E. K. Zhil’tsova, R. V. Donskikh, T. T. Tabagua, V. S. Apollonova
Publicado em 2015-11-01

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER

Por P. V. Krivorotko, E. K. Zhiltsova, L. P. Gigolaeva, Sh. M. Khadzhimatova, G. A. Dashyan, K. Yu. Zernov, E. S. Trufanova, А. S. Artemyeva, A. G. Kudaibergenova, V. F. Semiglazov
Publicado em 2017-12-01

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases

Por T.  Yu.  Semiglazova, S.  M.  Sharashenidze, S.  N.  Kerimova, V.   V. Klimenko, A. Yu.  Malygin, G.  A.  Dashyan, R.   M. Paltuev, V.  V.  Semiglazov, P.   V. Krivorotko, S.  N.  Novikov, V.   F. Semiglazov
Publicado em 2021-06-01

Neoadjuvant treatment for breast cancer

Por V. F. Semiglazov, V. V. Semiglazov, R. M. Paltuev, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, A. V. Komyakhov, Zh. V. Bryantseva, K. S. Nikolaev, D. Ye. Shchedrin, A. M. Yermochenkova
Publicado em 2014-07-01

EVALUATION OF MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHANGES OF BREAST CARCINOMAS AFTER NEOADJUVANT SYSTEMIC THERAPY

Por V. О. Bashlyk, V. F. Semiglazov, A. G. Kudaybergenova, A. S. Artem’eva, T. Yu. Semiglazova, V. S. Chirskiy, A. V. Komyakho, P. V. Krivorot’ko, V. V. Klimenko, Sh. M. Khadzhimatova, A. I. Tseluyko, S. S. Ereschenko
Publicado em 2018-04-01

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

Por G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Publicado em 2016-06-01

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER

Por V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov
Publicado em 2018-07-01

Immunology and immunotherapy in the complex treatment of malignant tumors

Por V. F. Semiglazov, A. I. Tseluiko, I. A. Baldueva, T. L. Nekhaeva, A. S. Artemyeva, A. G. Kudaybergenova, S. A. Protsenko, A. V. Novik, V. V. Semiglazov, R. V. Donskikh, T. Yu. Semiglazova, R. S. Pesotskiy, V. S. Apollonova, P. V. Krivorotko, A. M. Belyaev
Publicado em 2021-04-01

Biopsychosocial approach in the rehabilitation of patients with operable breast cancer

Por V. A. Kluge, T. Yu. Semiglazova, P. V. Krivorotko, E. V. Melnikova, V. V. Semiglazov, K. O. Kondrateva, S. G. Nazarova, M. A. Tynkasova, B. S. Kasparov, B. M. Adhamov, R. S. Pesotsky, K. Yu. Zernov, D. V. Kovlen, V. F. Semiglazov, A. V. Belyaev
Publicado em 2020-07-01